DOCSLIB.ORG

Mouse Spdya Conditional Knockout Project (CRISPR/Cas9)

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Mouse Spdya Conditional Knockout Project (CRISPR/Cas9) https://www.alphaknockout.com Mouse Spdya Conditional Knockout Project (CRISPR/Cas9) Objective: To create a Spdya conditional knockout Mouse model (C57BL/6J) by CRISPR/Cas-mediated genome engineering. Strategy summary: The Spdya gene (NCBI Reference Sequence: NM_029254 ; Ensembl: ENSMUSG00000052525 ) is located on Mouse chromosome 17. 7 exons are identified, with the ATG start codon in exon 2 and the TGA stop codon in exon 7 (Transcript: ENSMUST00000167641). Exon 2 will be selected as conditional knockout region (cKO region). Deletion of this region should result in the loss of function of the Mouse Spdya gene. To engineer the targeting vector, homologous arms and cKO region will be generated by PCR using BAC clone RP23-456J14 as template. Cas9, gRNA and targeting vector will be co-injected into fertilized eggs for cKO Mouse production. The pups will be genotyped by PCR followed by sequencing analysis. Note: Homozygous inactivation of this gene results in impaired telomere attachment to the nuclear envelope during early meiosis, abnormal chromosome pairing and homologous synapsis, and meiotic prophase I arrest in male and female germ cells leading to infertility in both sexes. Exon 2 starts from about 100% of the coding region. The knockout of Exon 2 will result in frameshift of the gene. The size of intron 1 for 5'-loxP site insertion: 4098 bp, and the size of intron 2 for 3'-loxP site insertion: 2131 bp. The size of effective cKO region: ~732 bp. The cKO region does not have any other known gene. Page 1 of 8 https://www.alphaknockout.com Overview of the Targeting Strategy Wildtype allele gRNA region 5' gRNA region 3' 1 2 3 7 Targeting vector Targeted allele Constitutive KO allele (After Cre recombination) Legends Exon of mouse Spdya Homology arm cKO region loxP site Page 2 of 8 https://www.alphaknockout.com Overview of the Dot Plot Window size: 10 bp Forward Reverse Complement Sequence 12 Note: The sequence of homologous arms and cKO region is aligned with itself to determine if there are tandem repeats. No significant tandem repeat is found in the dot plot matrix. So this region is suitable for PCR screening or sequencing analysis. Overview of the GC Content Distribution Window size: 300 bp Sequence 12 Summary: Full Length(7232bp) | A(29.85% 2159) | C(20.26% 1465) | T(32.65% 2361) | G(17.24% 1247) Note: The sequence of homologous arms and cKO region is analyzed to determine the GC content. No significant high GC-content region is found. So this region is suitable for PCR screening or sequencing analysis. Page 3 of 8 https://www.alphaknockout.com BLAT Search Results (up) QUERY SCORE START END QSIZE IDENTITY CHROM STRAND START END SPAN -------------------------------------------------------------------------------------------------------------- browser details YourSeq 3000 1 3000 3000 100.0% chr17 + 71553009 71556008 3000 browser details YourSeq 209 995 1707 3000 94.2% chr18 + 66522605 66986681 464077 browser details YourSeq 139 954 1170 3000 91.8% chr15 + 97668756 97669250 495 browser details YourSeq 132 994 1617 3000 81.9% chr1 - 192118430 192118940 511 browser details YourSeq 132 1543 2064 3000 91.2% chr11 + 6375061 6375692 632 browser details YourSeq 130 999 1170 3000 94.2% chr11 - 112637650 112637844 195 browser details YourSeq 130 1010 1635 3000 77.4% chr1 - 87830437 87830670 234 browser details YourSeq 127 1024 1280 3000 90.6% chr10 - 94972023 94972346 324 browser details YourSeq 127 994 1170 3000 90.2% chr12 + 55929340 55929513 174 browser details YourSeq 125 1078 1711 3000 76.2% chr14 + 34410184 34410631 448 browser details YourSeq 123 1016 1617 3000 81.0% chr1 + 41451857 41452092 236 browser details YourSeq 122 994 1170 3000 87.3% chr1 + 122345739 122345892 154 browser details YourSeq 121 994 1241 3000 93.1% chr17 - 49651867 49652115 249 browser details YourSeq 119 1006 1170 3000 91.9% chr5 - 121110050 121110264 215 browser details YourSeq 119 997 1175 3000 83.7% chr16 - 87854677 87854844 168 browser details YourSeq 119 994 1151 3000 93.6% chr14 + 88702901 88703068 168 browser details YourSeq 118 1018 1374 3000 92.4% chr1 - 150987968 150988361 394 browser details YourSeq 117 1004 1167 3000 94.9% chr10 - 118029358 118029605 248 browser details YourSeq 117 996 1173 3000 95.6% chr13 + 48293443 48293687 245 browser details YourSeq 115 984 1133 3000 92.9% chr13 - 38787610 38787843 234 Note: The 3000 bp section upstream of Exon 2 is BLAT searched against the genome. No significant similarity is found. BLAT Search Results (down) QUERY SCORE START END QSIZE IDENTITY CHROM STRAND START END SPAN ----------------------------------------------------------------------------------------------- browser details YourSeq 3000 1 3000 3000 100.0% chr17 + 71556741 71559740 3000 browser details YourSeq 1790 645 2995 3000 92.9% chr1 - 18015134 18017752 2619 browser details YourSeq 87 1170 1302 3000 89.5% chr11 - 52897200 52897665 466 browser details YourSeq 83 1136 1300 3000 83.9% chr1 + 35940927 35941085 159 browser details YourSeq 82 1136 1302 3000 80.0% chr15 + 79579607 79579756 150 browser details YourSeq 80 1204 1307 3000 92.8% chr14 - 45428668 45428784 117 browser details YourSeq 80 1162 1295 3000 90.0% chr2 + 67610844 67610986 143 browser details YourSeq 72 1132 1266 3000 80.7% chr4 + 8925147 8925268 122 browser details YourSeq 72 1136 1280 3000 92.1% chr11 + 102186749 102187177 429 browser details YourSeq 71 1170 1302 3000 94.0% chr3 - 87863110 87863418 309 browser details YourSeq 69 1136 1278 3000 86.1% chr11 + 89956356 89956490 135 browser details YourSeq 68 1175 1294 3000 88.7% chr16 + 32650351 32650483 133 browser details YourSeq 66 1173 1278 3000 94.8% chr17 - 27988233 27988363 131 browser details YourSeq 65 1143 1278 3000 92.3% chr6 - 33894764 33894904 141 browser details YourSeq 65 1174 1293 3000 89.2% chr5 + 31301699 31301842 144 browser details YourSeq 63 1210 1299 3000 84.3% chr5 - 66061008 66061082 75 browser details YourSeq 63 2156 2258 3000 77.4% chr17 - 48079654 48079752 99 browser details YourSeq 63 1169 1288 3000 94.5% chr13 - 93528118 93528251 134 browser details YourSeq 63 1159 1301 3000 89.9% chr3 + 139524267 139524512 246 browser details YourSeq 63 1222 1302 3000 89.8% chr2 + 104823820 104823900 81 Note: The 3000 bp section downstream of Exon 2 is BLAT searched against the genome. No significant similarity is found. Page 4 of 8 https://www.alphaknockout.com Gene and protein information: Spdya speedy/RINGO cell cycle regulator family, member A [ Mus musculus (house mouse) ] Gene ID: 70891, updated on 15-Oct-2019 Gene summary Official Symbol Spdya provided by MGI Official Full Name speedy/RINGO cell cycle regulator family, member A provided by MGI Primary source MGI:MGI:1918141 See related Ensembl:ENSMUSG00000052525 Gene type protein coding RefSeq status VALIDATED Organism Mus musculus Lineage Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; Murinae; Mus; Mus Also known as GS4; Spdy1; MLZ-465; 4921517J08Rik; 4930548B21Rik Expression Biased expression in testis adult (RPKM 7.5), CNS E18 (RPKM 0.8) and 10 other tissues See more Orthologs human all Genomic context Location: 17; 17 E1.3 See Spdya in Genome Data Viewer Exon count: 11 Annotation release Status Assembly Chr Location 108 current GRCm38.p6 (GCF_000001635.26) 17 NC_000083.6 (71526895..71589533) Build 37.2 previous assembly MGSCv37 (GCF_000001635.18) 17 NC_000083.5 (71901401..71938873) Chromosome 17 - NC_000083.6 Page 5 of 8 https://www.alphaknockout.com Transcript information: This gene has 4 transcripts Gene: Spdya ENSMUSG00000052525 Description speedy/RINGO cell cycle regulator family, member A [Source:MGI Symbol;Acc:MGI:1918141] Gene Synonyms 4921517J08Rik, 4930548B21Rik, Spdy1, speedy A1, speedy A2, speedy/ringo Location Chromosome 17: 71,552,061-71,589,533 forward strand. GRCm38:CM001010.2 About this gene This gene has 4 transcripts (splice variants), 186 orthologues, is a member of 1 Ensembl protein family and is associated with 17 phenotypes. Transcripts Name Transcript ID bp Protein Translation ID Biotype CCDS UniProt Flags Spdya-204 ENSMUST00000167641.7 1891 310aa ENSMUSP00000125912.1 Protein coding CCDS50178 Q5IBH7 TSL:5 GENCODE basic APPRIS P1 Spdya-202 ENSMUST00000124001.7 1247 283aa ENSMUSP00000118426.1 Protein coding CCDS50179 B2RWC8 Q5IBH7 TSL:1 GENCODE basic Spdya-203 ENSMUST00000144142.1 933 310aa ENSMUSP00000118994.1 Protein coding CCDS50178 Q5IBH7 TSL:1 GENCODE basic APPRIS P1 Spdya-201 ENSMUST00000064420.11 1877 309aa ENSMUSP00000063214.5 Protein coding - B8JJB9 TSL:1 GENCODE basic Page 6 of 8 https://www.alphaknockout.com 57.47 kb Forward strand 71.55Mb 71.56Mb 71.57Mb 71.58Mb 71.59Mb Genes Mettl4-ps1-202 >lncRNA (Comprehensive set... Mettl4-ps1-201 >transcribed unprocessed pseudogene Spdya-204 >protein coding Spdya-202 >protein coding Spdya-201 >protein coding Spdya-203 >protein coding Contigs CT010429.11 > Genes < Trmt61b-201lncRNA (Comprehensive set... < Trmt61b-202lncRNA < Trmt61b-203lncRNA Regulatory Build 71.55Mb 71.56Mb 71.57Mb 71.58Mb 71.59Mb Reverse strand 57.47 kb Regulation Legend CTCF Open Chromatin Promoter Promoter Flank Transcription Factor Binding Site Gene Legend Protein Coding Ensembl protein coding merged Ensembl/Havana Non-Protein Coding RNA gene pseudogene Page 7 of 8 https://www.alphaknockout.com Transcript: ENSMUST00000167641 37.47 kb Forward strand Spdya-204 >protein coding ENSMUSP00000125... MobiDB lite Low complexity (Seg) Pfam Cell cycle regulatory protein Speedy PANTHER PTHR31545 PTHR31545:SF4 All sequence SNPs/i... Sequence variants (dbSNP and all other sources) Variant Legend missense variant synonymous variant Scale bar 0 40 80 120 160 200 240 310 We wish to acknowledge the following valuable scientific information resources: Ensembl, MGI, NCBI, UCSC. Page 8 of 8.
Load more

Recommended publications
  • CDKN1B-Y88 Antibody Purified Rabbit Polyclonal Antibody (Pab) Catalog # Ap20721b
    10320 Camino Santa Fe, Suite G San Diego, CA 92121 Tel: 858.875.1900 Fax: 858.622.0609 CDKN1B-Y88 Antibody Purified Rabbit Polyclonal Antibody (Pab) Catalog # AP20721b Specification CDKN1B-Y88 Antibody - Product Information Application WB,E Primary Accession P46527 Other Accession Q60439 Reactivity Human Predicted Hamster Host Rabbit Clonality Polyclonal Isotype Rabbit IgG CDKN1B-Y88 Antibody - Additional Information Gene ID 1027 Other Names Cyclin-dependent kinase inhibitor 1B, Cyclin-dependent kinase inhibitor p27, Western blot analysis of lysate from MCF-7 p27Kip1, CDKN1B, KIP1 cell line, using CDKN1B-Y88 (Cat. #AP20721b). AP20721b was diluted at Target/Specificity 1:1000. A goat anti-rabbit IgG H&L(HRP) at This antibody is generated from a rabbit 1:5000 dilution was used as the secondary immunized with a KLH conjugated synthetic antibody. Lysate at 35ug. peptide between 81-113 amino acids from human. CDKN1B-Y88 Antibody - Background Dilution WB~~1:1000 Important regulator of cell cycle progression. Involved in G1 arrest. Potent inhibitor of cyclin Format E- and cyclin A-CDK2 complexes. Forms a Purified polyclonal antibody supplied in PBS complex with cyclin type D-CDK4 complexes with 0.09% (W/V) sodium azide. This antibody is purified through a protein A and is involved in the assembly, stability, and column, followed by peptide affinity modulation of CCND1- CDK4 complex purification. activation. Acts either as an inhibitor or an activator of cyclin type D-CDK4 complexes Storage depending on its phosphorylation state and/or Maintain refrigerated at 2-8°C for up to 2 stoichometry. weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw CDKN1B-Y88 Antibody - References cycles.
    [Show full text]
  • Replace This with the Actual Title Using All Caps
    UNDERSTANDING THE GENETICS UNDERLYING MASTITIS USING A MULTI-PRONGED APPROACH A Dissertation Presented to the Faculty of the Graduate School of Cornell University In Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy by Asha Marie Miles December 2019 © 2019 Asha Marie Miles UNDERSTANDING THE GENETICS UNDERLYING MASTITIS USING A MULTI-PRONGED APPROACH Asha Marie Miles, Ph. D. Cornell University 2019 This dissertation addresses deficiencies in the existing genetic characterization of mastitis due to granddaughter study designs and selection strategies based primarily on lactation average somatic cell score (SCS). Composite milk samples were collected across 6 sampling periods representing key lactation stages: 0-1 day in milk (DIM), 3- 5 DIM, 10-14 DIM, 50-60 DIM, 90-110 DIM, and 210-230 DIM. Cows were scored for front and rear teat length, width, end shape, and placement, fore udder attachment, udder cleft, udder depth, rear udder height, and rear udder width. Independent multivariable logistic regression models were used to generate odds ratios for elevated SCC (≥ 200,000 cells/ml) and farm-diagnosed clinical mastitis. Within our study cohort, loose fore udder attachment, flat teat ends, low rear udder height, and wide rear teats were associated with increased odds of mastitis. Principal component analysis was performed on these traits to create a single new phenotype describing mastitis susceptibility based on these high-risk phenotypes. Cows (N = 471) were genotyped on the Illumina BovineHD 777K SNP chip and considering all 14 traits of interest, a total of 56 genome-wide associations (GWA) were performed and 28 significantly associated quantitative trait loci (QTL) were identified.
    [Show full text]
  • VU Research Portal
    VU Research Portal Genetic architecture and behavioral analysis of attention and impulsivity Loos, M. 2012 document version Publisher's PDF, also known as Version of record Link to publication in VU Research Portal citation for published version (APA) Loos, M. (2012). Genetic architecture and behavioral analysis of attention and impulsivity. General rights Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. • Users may download and print one copy of any publication from the public portal for the purpose of private study or research. • You may not further distribute the material or use it for any profit-making activity or commercial gain • You may freely distribute the URL identifying the publication in the public portal ? Take down policy If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim. E-mail address: [email protected] Download date: 28. Sep. 2021 Genetic architecture and behavioral analysis of attention and impulsivity Maarten Loos 1 About the thesis The work described in this thesis was performed at the Department of Molecular and Cellular Neurobiology, Center for Neurogenomics and Cognitive Research, Neuroscience Campus Amsterdam, VU University, Amsterdam, The Netherlands. This work was in part funded by the Dutch Neuro-Bsik Mouse Phenomics consortium. The Neuro-Bsik Mouse Phenomics consortium was supported by grant BSIK 03053 from SenterNovem (The Netherlands).
    [Show full text]
  • Integrative Genomics Discoveries and Development at the Center for Applied Genomics at CHOP
    The Children’s Hospital of Philadelphia Integrative Genomics Discoveries and Development at The Center for Applied Genomics at CHOP Novel Genome-based Therapeutic Approaches Hakon Hakonarson, MD, PhD, Professor of Pediatrics CHOP’s Endowed Chair in Genetic Research Director, Center for Applied Genomics The Children’s Hospital of Philadelphia University of Pennsylvania, School of Medicine Duke Center for Applied Genomics and Precision Medicine 2019 Genomic and Precision Medicine Forum Nov 07, 2019 Genomics in the 21st Century Disclosures Dr. Hakonarson and CHOP own stock in Aevi Genomic Medicine Inc. developing anti-LIGHT therapy for IBD. Dr. Hakonarson is an inventor of technology involving therapeutic development of ADHD, GLA and HCCAA Novel Therapeutic Stem Cell/Gene Editing Approaches § iPS and stem cell therapy shows early promise § Gene therapy for LCA (RPE65) at CHOP via AAV § Targeted T cell therapy for cancer (UPENN/CHOP) § CRISPR-cas9 gene editing § Single cell sequencing The Center for Applied Genomics (CAG) at CHOP u Founded in June 2006 u Staff of 70 u Over 100 active disease projects with CHOP/Penn collaborators u TARGET: Genotype 100,000 children u ~450k GWAS samples >130k kids u IC - participation in future studies >85% u Database u Electronic Health Records u extensive information on each child u >1.2 million visits per year to Population Genomics Research CHOP Recruitment of CHOP/PENN HealthCare Network Patients u High-level of automation ADHD, Autism, Diabetes, IBD, Autoimmunity, Asthma/Atopy, Cancer, RDs - all high priority
    [Show full text]
  • Extensive Expansion of the Speedy Gene Family in Homininae and Functional Differentiation in Humans
    bioRxiv preprint doi: https://doi.org/10.1101/354886; this version posted June 26, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Extensive Expansion of the Speedy gene Family in Homininae and Functional Differentiation in Humans Liang Wang1,2†, Hui Wang1,3,4†, Hongmei Wang1,Yuhui Zhao2, Xiaojun Liu1, Gary Wong5, Qinong Ye6, Xiaoqin Xia7, George F. Gao2, Shan Gao1,8,* 1CAS Key Laboratory of Bio-medical Diagnostics, Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences, Suzhou 215163, China; 2CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, China; 3 Institute of Biomedical Engineering, Department of Engineering Science, Old Road Campus Research Building, University of Oxford, Oxford OX3 7DQ, UK; 4Oxford Suzhou Centre for Advanced Research (OSCAR), 388 Ruo Shui Road, Suzhou Industrial Park, Jiangsu 215123, China; 5Shenzhen Key Laboratory of Pathogen and Immunity, Guangdong Key Laboratory for Diagnosis and Treatment of Emerging Infectious Diseases, Shenzhen Third People’s Hospital, Shenzhen 518112, China; 6Department of Medical Molecular Biology, Beijing Institute of Biotechnology, Beijing 100850, China; 7Institutes of Hydrobiology, Chinese Academy of Sciences, Wuhan, Hubei, P. R. China, 430072; 8Medical College, Guizhou University, District of Huaxi, Guiyang 550025, China. †These authors contributed equally to this work 1 bioRxiv preprint doi: https://doi.org/10.1101/354886; this version posted June 26, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
    [Show full text]
  • On the Role of Chromosomal Rearrangements in Evolution
    On the role of chromosomal rearrangements in evolution: Reconstruction of genome reshuffling in rodents and analysis of Robertsonian fusions in a house mouse chromosomal polymorphism zone by Laia Capilla Pérez A thesis submitted for the degree of Doctor of Philosophy in Animal Biology Supervisors: Dra. Aurora Ruiz-Herrera Moreno and Dr. Jacint Ventura Queija Institut de Biotecnologia i Biomedicina (IBB) Departament de Biologia Cel·lular, Fisiologia i Immunologia Departament de Biologia Animal, Biologia Vegetal i Ecologia Universitat Autònoma de Barcelona Supervisor Supervisor PhD candidate Aurora Ruiz-Herrera Moreno Jacint Ventura Queija Laia Capilla Pérez Bellaterra, 2015 A la mare Al pare Al mano “Visto a la luz de la evolución, la biología es, quizás, la ciencia más satisfactoria e inspiradora. Sin esa luz, se convierte en un montón de hechos varios, algunos de ellos interesantes o curiosos, pero sin formar ninguna visión conjunta.” Theodosius Dobzhansky “La evolución es tan creativa. Por eso tenemos jirafas.” Kurt Vonnegut This thesis was supported by grants from: • Ministerio de Economía y Competitividad (CGL2010-15243 and CGL2010- 20170). • Generalitat de Catalunya, GRQ 1057. • Ministerio de Economía y Competitividad. Beca de Formación de Personal Investigador (FPI) (BES-2011-047722). • Ministerio de Economía y Competitividad. Beca para la realización de estancias breves (EEBB-2011-07350). Covers designed by cintamontserrat.blogspot.com INDEX Abstract 15-17 Acronyms 19-20 1. GENERAL INTRODUCTION 21-60 1.1 Chromosomal rearrangements
    [Show full text]
  • Genomic Heterogeneity of ALK Fusion Breakpoints in Non-Small-Cell Lung
    Modern Pathology (2018) 31, 791–808 © 2018 USCAP, Inc All rights reserved 0893-3952/18 $32.00 791 Genomic heterogeneity of ALK fusion breakpoints in non-small-cell lung cancer Jason N Rosenbaum1, Ryan Bloom2, Jason T Forys3, Jeff Hiken3, Jon R Armstrong3, Julie Branson4, Samantha McNulty4, Priya D Velu1, Kymberlie Pepin5, Haley Abel6, Catherine E Cottrell7, John D Pfeifer4, Shashikant Kulkarni8, Ramaswamy Govindan5, Eric Q Konnick9, Christina M Lockwood9 and Eric J Duncavage4 1Department of Pathology and Laboratory Medicine, University of Pennsylvania, The University of Pennsylvania Center for Personalized Diagnostics, Philadelphia, PA, USA; 2Unum Therapeutics, Cambridge, MA, USA; 3Cofactor Genomics, St Louis, MO, USA; 4Department of Pathology and Immunology, Division of Anatomic and Molecular Pathology, Washington University School of Medicine, St Louis, MO, USA; 5Department of Internal Medicine, Division of Medical Oncology, Washington University School of Medicine, St Louis, MO, USA; 6McDonnell Genome Institute, Washington University School of Medicine, St Louis, MO, USA; 7Nationwide Children’s Hospital, Institute for Genomic Medicine, Columbus, OH, USA; 8Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA and 9Department of Laboratory Medicine, University of Washington, Seattle, WA, USA In lung adenocarcinoma, canonical EML4-ALK inversion results in a fusion protein with a constitutively active ALK kinase domain. Evidence of ALK rearrangement occurs in a minority (2–7%) of lung adenocarcinoma, and only ~ 60% of these patients will respond to targeted ALK inhibition by drugs such as crizotinib and ceritinib. Clinically, targeted anti-ALK therapy is often initiated based on evidence of an ALK genomic rearrangement detected by fluorescence in situ hybridization (FISH) of interphase cells in formalin-fixed, paraffin-embedded tissue sections.
    [Show full text]
  • Anti-SPDYA Polyclonal Antibody Cat: K003260P Summary
    Anti-SPDYA Polyclonal Antibody Cat: K003260P Summary: 【Product name】: Anti-SPDYA antibody 【Source】: Rabbit 【Isotype】: IgG 【Species reactivity】: Human Mouse Rat 【Swiss Prot】: Q5MJ70 【Gene ID】: 245711 【Calculated】: MW:36kDa 【Observed】: MW:45kDa 【Purification】: Affinity purification 【Tested applications】: WB 【Recommended dilution】: WB 1:500-2000. 【WB Positive sample】: A549,Mouse ovary,Mouse testis 【Subcellular location】: Nucleus 【Immunogen】: Recombinant protein of human SPDYA 【Storage】: Shipped at 4°C. Upon delivery aliquot and store at -20°C Background: Speedy A, also known as SPDYA, SPDY1, Ringo3 or SPY1, is a 313 amino acid protein that localizes to the nucleus and belongs to the speedy/ringo family. Expressed at high levels in testis and at lower levels in brain, kidney, heart, bone marrow, colon, lung, liver spleen and placenta, Speedy A functions to regulate the G1/S phase transition of the cell cycle, specifically by binding to and activating Cdc2 p34, Cdk2 and p27. Additionally, Speedy A mediates cell survival during DNA damage, suggesting that Speedy A plays a role in proper cell cycle progression throughout the life of the cell. Multiple isoforms of Speedy A exist due to alternative splicing events. The gene encoding Speedy A maps to human chromosome 2, which encodes over 1,400 genes and comprises nearly 8% of the human genome. Sales:[email protected] For research purposes only. Tech:[email protected] Please visit www.solarbio.com for a more product information Verified picture Western blot analysis with SPDYA antibody diluted at 1:1000 Sales:[email protected] For research purposes only. Tech:[email protected] Please visit www.solarbio.com for a more product information.
    [Show full text]
  • Systematic Evaluation of Genes and Genetic Variants Associated with Type 1 Diabetes Susceptibility
    Systematic Evaluation of Genes and Genetic Variants Associated with Type 1 Diabetes Susceptibility This information is current as Ramesh Ram, Munish Mehta, Quang T. Nguyen, Irma of September 24, 2021. Larma, Bernhard O. Boehm, Flemming Pociot, Patrick Concannon and Grant Morahan J Immunol published online 24 February 2016 http://www.jimmunol.org/content/early/2016/02/19/jimmun ol.1502056 Downloaded from Supplementary http://www.jimmunol.org/content/suppl/2016/02/19/jimmunol.150205 Material 6.DCSupplemental http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication by guest on September 24, 2021 *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2016 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. Published February 24, 2016, doi:10.4049/jimmunol.1502056 The Journal of Immunology Systematic Evaluation of Genes and Genetic Variants Associated with Type 1 Diabetes Susceptibility Ramesh Ram,*,† Munish Mehta,*,† Quang T. Nguyen,*,† Irma Larma,*,† Bernhard O. Boehm,‡,x Flemming Pociot,{ Patrick Concannon,‖,# and Grant Morahan*,† Genome-wide association studies have found >60 loci that confer genetic susceptibility to type 1 diabetes (T1D).
    [Show full text]
  • VU Research Portal
    VU Research Portal Genetic architecture and behavioral analysis of attention and impulsivity Loos, M. 2012 document version Publisher's PDF, also known as Version of record Link to publication in VU Research Portal citation for published version (APA) Loos, M. (2012). Genetic architecture and behavioral analysis of attention and impulsivity. General rights Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. • Users may download and print one copy of any publication from the public portal for the purpose of private study or research. • You may not further distribute the material or use it for any profit-making activity or commercial gain • You may freely distribute the URL identifying the publication in the public portal ? Take down policy If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim. E-mail address: [email protected] Download date: 28. Sep. 2021 Chapter 5 Independent genetic loci for sensorimotor gating and attentional performance in BXD recombinant inbred strains Maarten Loos, Jorn Staal, Tommy Pattij, Neuro-BSIK Mouse Phenomics consortium, August B. Smit, Sabine Spijker Genes Brain and Behavior, In Press 87 88 Sensorimotor gating and attention Abstract A startle reflex in response to an intense acoustic stimulus is inhibited when a barely detectable pulse precedes the startle stimulus by 30 – 500 ms.
    [Show full text]
  • Pharmacogenomics of Ventricular Conduction in Multi-Ethnic Populations
    PHARMACOGENOMICS OF VENTRICULAR CONDUCTION IN MULTI-ETHNIC POPULATIONS Amanda Anne Seyerle A dissertation submitted to the faculty at the University of North Carolina at Chapel Hill in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the Department of Epidemiology in the Gillings School of Global Public Health. Chapel Hill 2016 Approved by: Christy L. Avery Kari E. North Eric A. Whitsel Til Stürmer Craig Lee ©2016 Amanda Anne Seyerle ALL RIGHTS RESERVED ii ABSTRACT Amanda Anne Seyerle: Pharmacogenomics of Ventricular Conduction in Multi-Ethnic Populations (Under the direction of Christy L. Avery) Adverse drug reactions (ADRs) pose a serious public health burden, yet the role of genetics in drug response remains incompletely characterized. Thiazide diuretics, commonly used anti-hypertensives, may cause QT interval (QT) prolongation, a major drug development barrier that increases risk for highly fatal and difficult to predict ventricular arrhythmias. We thus examined whether common SNPs modified the association between thiazide use (17% mean prevalence) and QT or its component parts (QRS interval, JT interval) by performing ancestry-specific, trans-ethnic, and cross-phenotype genome-wide analyses of European (66%), African American (15%), and Hispanic (19%) populations (N- 78,199). Analyses leveraged longitudinal data, incorporated corrected standard errors to account for underestimation of interaction estimate variances, and evaluated evidence for pathway enrichment. Although no loci achieved genome-side significance (P<5x10-8), we found suggestive evidence (P<5x10-6) for SNPs modifying the thiazide-QT association at 22 loci, including biologically plausible ion transport loci (e.g. NELL1, KCNQ3). Given our highly plausible, but only suggestive findings and our observational cohort setting, we next examined the influence of prevalent user bias and exposure misclassification on pharmacogenomics studies conducted in observational settings.
    [Show full text]
  • Molecular Conservation of Estrogen-Response Associated with Cell Cycle Regulation, Hormonal Carcinogenesis and Cancer in Zebrafi
    Lam et al. BMC Medical Genomics 2011, 4:41 http://www.biomedcentral.com/1755-8794/4/41 RESEARCHARTICLE Open Access Molecular conservation of estrogen-response associated with cell cycle regulation, hormonal carcinogenesis and cancer in zebrafish and human cancer cell lines Siew Hong Lam2,4, Serene GP Lee1, Chin Y Lin1,3,5, Jane S Thomsen1, Pan Y Fu1, Karuturi RK Murthy1, Haixia Li1, Kunde R Govindarajan1, Lin CH Nick1, Guillaume Bourque1, Zhiyuan Gong2, Thomas Lufkin1, Edison T Liu1* and Sinnakaruppan Mathavan1* Abstract Background: The zebrafish is recognized as a versatile cancer and drug screening model. However, it is not known whether the estrogen-responsive genes and signaling pathways that are involved in estrogen-dependent carcinogenesis and human cancer are operating in zebrafish. In order to determine the potential of zebrafish model for estrogen-related cancer research, we investigated the molecular conservation of estrogen responses operating in both zebrafish and human cancer cell lines. Methods: Microarray experiment was performed on zebrafish exposed to estrogen (17b-estradiol; a classified carcinogen) and an anti-estrogen (ICI 182,780). Zebrafish estrogen-responsive genes sensitive to both estrogen and anti-estrogen were identified and validated using real-time PCR. Human homolog mapping and knowledge-based data mining were performed on zebrafish estrogen responsive genes followed by estrogen receptor binding site analysis and comparative transcriptome analysis with estrogen-responsive human cancer cell lines (MCF7, T47D and Ishikawa). Results: Our transcriptome analysis captured multiple estrogen-responsive genes and signaling pathways that increased cell proliferation, promoted DNA damage and genome instability, and decreased tumor suppressing effects, suggesting a common mechanism for estrogen-induced carcinogenesis.
    [Show full text]